UALCAN

Preprint of our comprehensive breast cancer data analysis platform MammOnc-DB with over 20,000 breast cancer patient sample data (resource.path.uab.edu/MammOnc-Home.h……) is now online at: researchsquare.com/article/rs-492… @UABPathology, @UABHeersink, @theNCI, @NCIDataSci , @NCIgenomics , @BCRFAlabama

UALCAN (ualcan.path.uab.edu) has been visited over 1.5 million times and cited over 6,000 times during last 8 years, enabling many discoveries. Thanks to collaborators and users for their kind support. @UABPathology, @UABHeersink, @theNCI, @NCIgenomics, @NCIDataSci, #Cancer

Thanks to the innovation of @uabpathology faculty @Varambally_S and @darshan_sc, cancer research is now mobile: The team has created a free mobile app based on their comprehensive cancer proteogenomic platform, @Now_UALCAN. bit.ly/40ZH4FR

UALCAN team is happy to release "UALCAN Mobile", a free app for analyzing #TCGA cancer gene expression data on the go. ualcan.path.uab.edu. @UABPathology, @ONealCancerUAB, @UABHeersink, @InformaticsUAB, @bcmhouston, #CancerResearch @NCIDataSci, @theNCI, @NCIgenomics

UALCAN (ualcan.path.uab.edu) analysis show that PD-L1 and IDO1, regulators of immune responses and therapeutic targets are increased and co-expressed in subtype of bladder cancers. @BladderCancerUS, #CancerResearch, @NCIgenomics, @NCIDataSci, @UABPathology, #TCGA

Our collaborative study "Global impact of somatic structural variation on the cancer proteome" is online @ nature.com/articles/s4146… Proteomics data are deposited in UALCAN platform @ ualcan.path.uab.edu, @UABPathology, @ONealCancerUAB, @UABHeersink, @bcmhouston, #Cancer

A perspective on using cancer proteomics to identify targets was published with our collaborators.lnkd.in/etKd_Pv4. The cancer data analysis platform UALCAN, ualcan.path.uab.edu provides the Clinical Proteomic Tumor Analysis Consortium data @UABPathology, #Cancer

Updates to UALCAN (ualcan.path.uab.edu), the comprehensive cancer "Omics" data analysis platform was presented at @AACR Annual meeting today at Orlando. @UABPathology, @ONealCancerUAB, @UABHeersink, @darshan_sc, @Varambally_S , @DrNetto , @NCIDataSci, @NCIgenomics, #Cancer

UALCAN (ualcan.path.uab.edu) tops 1 million visits. uab.edu/news/research/… @theNCI , @NCIgenomics, @Americancancer, #TCGA, #CPTAC, #Cancer, #CancerResearch

We had a cake cutting to celebrate "Million" site visit for comprehensive #cancer data analysis platform UALCAN (ualcan.path.uab.edu) at the @UABPathology department research retreat today. @DrNetto, @darshan_sc

We are extremely honored to note that we (ualcan.path.uab.edu) reached the landmark of a “Million” site visits. @UABPathology, @ONealCancerUAB, @InformaticsUAB, @UABHeersink, @bcmhouston, @NCIgenomics, @NCIDataSci, @AmericanCancer, #Cancer, #teamwork

Received a kind note today "Thank you for developing UALCAN. I don't think my day goes by without visiting it at least once. UALCAN is extensively used in industries developing drug targets". Purpose is served when discoveries are made and #Cancer targets identified @NCIgenomics

Our first study on EZH2 in cancer, published in Nature (2002) reached 3,000 citations today (2022). Many exciting investigations have been done on it during the last 20 years in various cancers and diseases now. It has got FDA approved inhibitor as well. #Cancer.

UALCAN (ualcan.path.uab.edu) now provides list of potential #Cancer prognostic markers with Kaplan–Meier curves at :ualcan.path.uab.edu/analysis-surv.… @UABPathology, @NCIDataSci , @NCIgenomics, @ONealCancerUAB, @UABHeersink, @bcmhouston, @ACS_Research.

UALCAN (ualcan.path.uab.edu), the integrative cancer data analysis portal reached 3,000 citations. We are thankful to all the users and suggestions @UABPathology, @ONealCancerUAB, @UABHeersink, @InformaticsUAB, @NCIgenomics, @NCIDataSci, @bcmhouston, #Cancer, Yes! You All Can

@RaisBahrami @Varambally_S @sonpavde @DrNetto @UABHeersink @ONealCancerUAB @UABPathology @BladderCancerUS @UABUrology @JedUro1 @uabprecisionmed @Umanne Thanks Soroush, @JedUro1 put great thoughts and efforts in to this.

@Varambally_S @sonpavde @DrNetto @UABHeersink @ONealCancerUAB @UABPathology @BladderCancerUS @UABUrology Congrats @JedUro1 @Varambally_S for leading this powerhouse multiD team! Outstanding figure that wraps up so much great work! #bladdercancer

Thrilled to share our study "ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors". From JCI Insight. insight.jci.org/articles/view/… @sonpavde, @DrNetto, @UABHeersink, @ONealCancerUAB, @UABPathology,@BladderCancerUS, @UABUrology

Our study "ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors". Appeared in JCI Insight. insight.jci.org/articles/view/… @JedUro1, @sonpavde, @DrNetto, @UABHeersink, @ONealCancerUAB, @UABPathology, @UABUrology, @darshan_sc, #Cancer

Thrilled to see kind words for comprehensive and user-friendly #cancer data analysis portal, UALCAN (ualcan.path.uab.edu) from experts like Dr. Bradner! @UABPathology, @UABHeersink, @InformaticsUAB, @ONealCancerUAB, @NCIgenomics, @NCIDataSci, @NCIResearchCtr, @NCICancerCtrl

Our new manuscript "Proteogenomic characterization of 2002 cancers" is online at Nature Communication nature.com/articles/s4146…. Data is integrated in to UALCAN (ualcan.path.uab.edu). @UABPathology, @ONealCancerUAB, @UABHeersink, @NCIDataSci, @NCIgenomics, @bcmhouston, #Cancer

UALCAN (ualcan.path.uab.edu) now provides compendium of mass spectrometry-based proteomics data of over 2000 tumors, molecular subtypes and associated pathways @UABPathology, @ONealCancerUAB, @UABHeersink, @bcmhouston, @NCIDataSci, @NCIgenomics,@UMICH, #Cancer, #TCGA, #CPTAC